Physician profile
Fraser J Leversedge
NPI 1508805912
$325,972.51
in general payments reported to CMS, 2019-2025
24 companies · $54K in 2025
The $54K reported for 2025 was more than what 98% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112K · 2020: $34K · 2021: $15K · 2022: $34K · 2023: $61K · 2024: $16K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $69K · Travel and Lodging: $24K · Consulting Fee: $14K · Education: $9,600 · Food and Beverage: $7,898 · Honoraria: $6,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $69,262.50 |
| Travel and Lodging | $23,569.45 |
| Consulting Fee | $14,150.00 |
| Education | $9,600.00 |
| Food and Beverage | $7,897.77 |
| Honoraria | $6,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $265,424.60 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Kls-Martin L.P. | $14,294.83 | 2025 | |
| Checkpoint Surgical, INC | $13,104.55 | 2019-2025 | Checkpoint Stimulators |
| Skeletal Dynamics INC | $11,090.90 | 2021-2025 | Geminus, Ijs, Align |
| Bioventus LLC | $8,090.56 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Medartis INC. | $3,287.80 | 2019-2025 | Touch, Aptus |
| Endo Pharmaceuticals INC. | $3,225.68 | 2019-2023 | Xiaflex |
| Stryker Corporation | $2,131.04 | 2019-2025 | Conextions Tr Tendon Repair System-Implant Mechanism, Variax, Rayhack |
| Tulavi Therapeutics, INC. | $1,808.78 | 2025 | Allay Nerve Cap - Small Nerve Set |
| Alafair Biosciences, INC. | $1,564.80 | 2021-2025 | Versawrap |
| Illuminoss Medical, INC. | $315.74 | 2021-2022 | |
| Acumed LLC | $300.66 | 2023-2025 | Acumed, Acumed, Inframe Implant |
| Trimed, INC. | $293.59 | 2020-2022 | |
| Integra Lifesciences Corporation | $153.03 | 2021-2023 | Tenoglide |
| Endo USA, INC. | $134.55 | 2024-2025 | Xiaflex |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $133.56 | 2023 | Tapestry |
| Smith+Nephew, INC. | $129.79 | 2022 | |
| Arthrosurface Incorporated | $129.41 | 2019 | |
| Depuy Synthes Sales INC. | $115.38 | 2019 | |
| Biopro, INC. | $82.63 | 2024 | Mod Thumb |
| Trice Medical, INC. | $50.00 | 2020 | |
| Ossur Americas, INC. | $46.88 | 2024 | I-Digits Quantum |
| Exsomed Corporation | $46.77 | 2020 | |
| Siemens Medical Solutions USA, INC. | $16.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fraser Leversedge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.